Corticosteroid regulation of gonadotropin and prolactin secretion in the rat

Darrell W Brann, Carla D. Putnam, Virendra B. Mahesh, Virendra B. Mahesh

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

The purpose of this study was to determine if glucocorticoids had any direct effects on the release of gonadotropin. In estrogen-primed ovariectomized immature rats, triamcinolone acetonide and deoxycorticosterone (1 mg/kg BW) caused a surge in both serum LH and FSH levels. Dexametha- sone treatment (0.05 mg/kg BW) resulted in a highly significant selective release of FSH. Cortisol (1 mg/kg BW) suppressed serum FSH levels. A systematic dose-response study showed that triamcinolone acetonide significantly released LH and FSH and suppressed PRL at all doses tested (range, 0.25-4 mg/kg BW). Deoxycorticosterone was not as potent as triamcinolone acetonide and only doses greater than 0.8-1 mg/kg BW significantly released LH and FSH. Dexamethasone selectively released FSH at low doses (0.01, 0.02, 0.05, and 0.1 mg/kg BW) and inhibited LH at higher doses (0.5 and 1.0 mg/kg BW). A single low dose of dexamethasone (0.02 mg/kg BW) was found to significantly release LH. With respect to PRL secretion, a biphasic effect of dexamethasone was observed in that the lowest dose (0.01 mg/kg BW) stimulated PRL release while the highest dose (1.0 mg/kg BW) significantly inhibited PRL release. Triamicolone acetonide and deoxycorticosterone were found to require estrogen priming for their effects on gonadotropin secretion. The findings in this study raise the possibility that the beneficial effects seen with corticosteroids in inducing ovulation in polycystic ovarian syndrome may be due, in part, to their direct effects upon the release of gonadotropins.

Original languageEnglish (US)
Pages (from-to)159-166
Number of pages8
JournalEndocrinology
Volume126
Issue number1
DOIs
StatePublished - Jan 1 1990

Fingerprint

Gonadotropins
Triamcinolone Acetonide
Prolactin
Desoxycorticosterone
Dexamethasone
Adrenal Cortex Hormones
Estrogens
Polycystic Ovary Syndrome
Ovulation
Serum
Glucocorticoids
Hydrocortisone

ASJC Scopus subject areas

  • Endocrinology

Cite this

Corticosteroid regulation of gonadotropin and prolactin secretion in the rat. / Brann, Darrell W; Putnam, Carla D.; Mahesh, Virendra B.; Mahesh, Virendra B.

In: Endocrinology, Vol. 126, No. 1, 01.01.1990, p. 159-166.

Research output: Contribution to journalArticle

Brann, Darrell W ; Putnam, Carla D. ; Mahesh, Virendra B. ; Mahesh, Virendra B. / Corticosteroid regulation of gonadotropin and prolactin secretion in the rat. In: Endocrinology. 1990 ; Vol. 126, No. 1. pp. 159-166.
@article{6ab2a3dd1a2043f7b574575c2b316460,
title = "Corticosteroid regulation of gonadotropin and prolactin secretion in the rat",
abstract = "The purpose of this study was to determine if glucocorticoids had any direct effects on the release of gonadotropin. In estrogen-primed ovariectomized immature rats, triamcinolone acetonide and deoxycorticosterone (1 mg/kg BW) caused a surge in both serum LH and FSH levels. Dexametha- sone treatment (0.05 mg/kg BW) resulted in a highly significant selective release of FSH. Cortisol (1 mg/kg BW) suppressed serum FSH levels. A systematic dose-response study showed that triamcinolone acetonide significantly released LH and FSH and suppressed PRL at all doses tested (range, 0.25-4 mg/kg BW). Deoxycorticosterone was not as potent as triamcinolone acetonide and only doses greater than 0.8-1 mg/kg BW significantly released LH and FSH. Dexamethasone selectively released FSH at low doses (0.01, 0.02, 0.05, and 0.1 mg/kg BW) and inhibited LH at higher doses (0.5 and 1.0 mg/kg BW). A single low dose of dexamethasone (0.02 mg/kg BW) was found to significantly release LH. With respect to PRL secretion, a biphasic effect of dexamethasone was observed in that the lowest dose (0.01 mg/kg BW) stimulated PRL release while the highest dose (1.0 mg/kg BW) significantly inhibited PRL release. Triamicolone acetonide and deoxycorticosterone were found to require estrogen priming for their effects on gonadotropin secretion. The findings in this study raise the possibility that the beneficial effects seen with corticosteroids in inducing ovulation in polycystic ovarian syndrome may be due, in part, to their direct effects upon the release of gonadotropins.",
author = "Brann, {Darrell W} and Putnam, {Carla D.} and Mahesh, {Virendra B.} and Mahesh, {Virendra B.}",
year = "1990",
month = "1",
day = "1",
doi = "10.1210/endo-126-1-159",
language = "English (US)",
volume = "126",
pages = "159--166",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Corticosteroid regulation of gonadotropin and prolactin secretion in the rat

AU - Brann, Darrell W

AU - Putnam, Carla D.

AU - Mahesh, Virendra B.

AU - Mahesh, Virendra B.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - The purpose of this study was to determine if glucocorticoids had any direct effects on the release of gonadotropin. In estrogen-primed ovariectomized immature rats, triamcinolone acetonide and deoxycorticosterone (1 mg/kg BW) caused a surge in both serum LH and FSH levels. Dexametha- sone treatment (0.05 mg/kg BW) resulted in a highly significant selective release of FSH. Cortisol (1 mg/kg BW) suppressed serum FSH levels. A systematic dose-response study showed that triamcinolone acetonide significantly released LH and FSH and suppressed PRL at all doses tested (range, 0.25-4 mg/kg BW). Deoxycorticosterone was not as potent as triamcinolone acetonide and only doses greater than 0.8-1 mg/kg BW significantly released LH and FSH. Dexamethasone selectively released FSH at low doses (0.01, 0.02, 0.05, and 0.1 mg/kg BW) and inhibited LH at higher doses (0.5 and 1.0 mg/kg BW). A single low dose of dexamethasone (0.02 mg/kg BW) was found to significantly release LH. With respect to PRL secretion, a biphasic effect of dexamethasone was observed in that the lowest dose (0.01 mg/kg BW) stimulated PRL release while the highest dose (1.0 mg/kg BW) significantly inhibited PRL release. Triamicolone acetonide and deoxycorticosterone were found to require estrogen priming for their effects on gonadotropin secretion. The findings in this study raise the possibility that the beneficial effects seen with corticosteroids in inducing ovulation in polycystic ovarian syndrome may be due, in part, to their direct effects upon the release of gonadotropins.

AB - The purpose of this study was to determine if glucocorticoids had any direct effects on the release of gonadotropin. In estrogen-primed ovariectomized immature rats, triamcinolone acetonide and deoxycorticosterone (1 mg/kg BW) caused a surge in both serum LH and FSH levels. Dexametha- sone treatment (0.05 mg/kg BW) resulted in a highly significant selective release of FSH. Cortisol (1 mg/kg BW) suppressed serum FSH levels. A systematic dose-response study showed that triamcinolone acetonide significantly released LH and FSH and suppressed PRL at all doses tested (range, 0.25-4 mg/kg BW). Deoxycorticosterone was not as potent as triamcinolone acetonide and only doses greater than 0.8-1 mg/kg BW significantly released LH and FSH. Dexamethasone selectively released FSH at low doses (0.01, 0.02, 0.05, and 0.1 mg/kg BW) and inhibited LH at higher doses (0.5 and 1.0 mg/kg BW). A single low dose of dexamethasone (0.02 mg/kg BW) was found to significantly release LH. With respect to PRL secretion, a biphasic effect of dexamethasone was observed in that the lowest dose (0.01 mg/kg BW) stimulated PRL release while the highest dose (1.0 mg/kg BW) significantly inhibited PRL release. Triamicolone acetonide and deoxycorticosterone were found to require estrogen priming for their effects on gonadotropin secretion. The findings in this study raise the possibility that the beneficial effects seen with corticosteroids in inducing ovulation in polycystic ovarian syndrome may be due, in part, to their direct effects upon the release of gonadotropins.

UR - http://www.scopus.com/inward/record.url?scp=0025181702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025181702&partnerID=8YFLogxK

U2 - 10.1210/endo-126-1-159

DO - 10.1210/endo-126-1-159

M3 - Article

C2 - 2104585

AN - SCOPUS:0025181702

VL - 126

SP - 159

EP - 166

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 1

ER -